Albena Patroneva, M.D., MBA, is Senior Vice President, Clinical Development at Neurogene. Dr. Patroneva is a highly accomplished neurologist and epileptologist with over 25 years of industry experience in neuroscience drug development and medical affairs. She joined Neurogene in 2022 and is responsible for overseeing global clinical development and operational planning of the company’s pipeline, as well as leading the medical affairs team. Prior to her work at Neurogene, Dr. Patroneva served as the Chief Medical Officer at Marinus Pharmaceuticals, overseeing clinical development, clinical operations and regulatory affairs for multiple neurology and orphan disease programs. Dr. Patroneva also served as Vice President of the Clinical Development and Medical Affairs departments at Harmony Biosciences, where she established and initiated start-up activities for four neurology orphan indications. Earlier, Dr. Patroneva served as Vice President of Global Medical Affairs and Global Head of Multiple Sclerosis and Neurodegenerative Disorders at TEVA Pharmaceuticals, and has held other roles in CNS drug development, leading the full spectrum of clinical development activities from first-in-human trials through product launch and life cycle management. Dr. Patroneva received her M.D. from the Medical Academy of Sofia in Bulgaria. She holds board certification in neurology and previously worked in academia, serving as Head of the EEG Lab at the Military Medical Academy of Sofia in Bulgaria, and as Assistant Professor of Neurophysiology at the Alexandrov Medical Hospital in Sofia. Dr. Patroneva also earned an MBA in Health Management from Assen Zlatarov University in Bulgaria.